-
Continuous Avoidance Cost in Biosimilar: A Budget Impact Analysis on the Basis of Clinical Trial Model and RWD in Brazil / LATAM / LMIC .
Mar 10, 2025, 14:00 PM -
Identifying Drivers for the Timely Referral of Patients for a Rare Disease Diagnosis: A Cross-Sectional Survey of Physicians in the United States
Mar 10, 2025, 14:00 PM -
Examining The Association Of Self-Reported Condition Severity And Excessive Daytime Sleepiness Severity With Health-Related Outcomes Among Individuals With Narcolepsy In The United States
Mar 10, 2025, 14:00 PM -
Real-World Healthcare Resource Utilization and Related Costs Associated with Ovarian Cancer in the Brazilian Private Market
Mar 10, 2025, 14:00 PM -
Health and Economic Impact Analysis of Uncontrolled Hemophilia Patients in Colombia
Mar 10, 2025, 14:00 PM -
Pathways to MBS Funding for In-Vitro Diagnostics: Timelines and Success Rates in Australia
Mar 10, 2025, 14:00 PM -
What's Cost Got To Do With It? A Review of Key Issues Related to Costs in Health Technology Assessments in Non-Small-Cell Lung Cancer
Mar 10, 2025, 14:00 PM -
Patient's Experience of Ulcerative Colitis: A Conceptual Model Based on Qualitative Interviews
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns and Survival Outcomes of Advanced Non-Small Cell Lung Cancer Medicare Patients
Mar 10, 2025, 14:00 PM -
Navigating Scarcity: Leveraging AI to Address the Challenges of Identifying Rare Disease Key Opinion Leaders
Mar 10, 2025, 14:00 PM -
Mind The Gap: Delays Between Vaccine Licensure And NITAG Recommendation In The US Versus Europe
Mar 10, 2025, 14:00 PM -
Developing a Large Language Model-Based Simulation for P&T Committees: Methodology and Inputs for Realistic Dynamics
Mar 10, 2025, 14:00 PM -
Operational Definitions in Practice: Finding and Evaluating Algorithms for Identifying Patients with Cervical and Uterine Cancer for Real World Data Studies
Mar 10, 2025, 14:00 PM -
Economic Burden and Healthcare Resource Utilization (HCRU) Associated with High-Risk Papillary Stage Ta & T1 (PAPTa1) Non-Muscle Invasive Bladder Cancer (NMIBC) Patients, 2008-2019
Mar 10, 2025, 14:00 PM -
Radiofrequency Renal Denervation for Uncontrolled Hypertension: A Cost-Effectiveness Analysis Based on the SPYRAL HTN-ON MED Trial for the Colombian Healthcare System
Mar 10, 2025, 14:00 PM -
A Real-World Perspective of Quadruple Treatment Patterns for 1L Multiple Myeloma Patients across North and South America, Europe and Asia
Mar 10, 2025, 14:00 PM -
Patient and Physician Perspectives on Attributes of IO-Containing Perioperative Treatments in Potentially Resectable, Non-metastatic Non-small Cell Lung Cancer (NSCLC)
Mar 10, 2025, 14:00 PM -
Persistence of Infliximab Biosimilar versus Originator in Patients with Crohn's Disease: a Retrospective Cohort Study in China
Mar 10, 2025, 14:00 PM -
Examining Health Behaviour of Inviduals Diagnosed With Polycystic Ovary Syndrome
Mar 10, 2025, 14:00 PM -
The Real-World Cost-Effectiveness of Faricimab Versus Existing and Future Biosimilars in Patients with Neovascular Age-Related Macular Degeneration in the UK
Mar 10, 2025, 14:00 PM
